Mineralys Therapeutics In... (MLYS)
12.83
1.06 (9.01%)
At close: Apr 09, 2025, 3:59 PM
13.01
1.40%
Pre-market: Apr 10, 2025, 08:11 AM EDT
13F Institute Ownership
Total Institutes of 109 in Mineralys Therapeutics expanded their positions with an increase of 109 investors compared to the previous quarter. An additional 46.48M shares, as total invested capital grew by $571.94M with ownership percentage increasing from 0.00% to 93.04%.
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio |
|---|---|---|---|---|---|
| Catalys Pacific, LLC | 17.30% | 8.64M | +0.00% | 106.41M | 91.82% |
| Samsara Biocapital, LLC | 10.16% | 5.07M | +0.00% | 62.47M | 8.57% |
| Ra Capital Management, L.p. | 9.71% | 4.85M | +0.00% | 59.72M | 0.79% |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.